The lower-grade gliomas (LGGs), WHO grade II and III, mainly include three subtypes with histological and molecular characteristics: IDH mutant diffuse astrocytomas, IDH wild type diffuse astrocytomas and IDH mutations combined with 1p/19q codeletions in oligodendrogliomas (Louis et al., 2016). Here, IDH1 is linked to diffuse astrocytoma.